We’re thrilled to announce our partnership with QL AG to develop dairy proteins!
QL AG will tap into Ginkgo’s extensive capabilities in strain engineering to support its goal of providing the market with high-quality nutritionally equivalent dairy proteins.
The alternative dairy market has grown by tens of billions of dollars in recent years.
Yet, current dairy alternatives still fall short of consumer criteria on critical factors like taste and texture.
“By accessing Ginkgo’s platform, QL AG can help reduce the cost of producing dairy proteins with fermentation. We are excited to pursue our goal of making a quantum leap in alternative agriculture by leveraging Ginkgo’s unique capabilities in producing strains at high titers and scaling fermentation processes.”
—Roger Föhn, CEO and co-founder of QL AG
Dairy proteins provide an exciting opportunity to leverage our platform, as they have traditionally presented product developers with significant challenges around protein productivity, economics, and functionality for efficacy across different applications. We aim to solve such challenges with our deep expertise in protein engineering, novel bioactivity and biochemistry identification, high-throughput expression, functional studies and scale-up capabilities.
To learn more about Ginkgo Protein Production Services, please visit https://www.ginkgobioworks.com/offerings/protein-services/.
Find the full press release here along with all of the latest news from the Ginkgo team.
